1.74
Precedente Chiudi:
$1.65
Aprire:
$1.68
Volume 24 ore:
515.96K
Relative Volume:
1.06
Capitalizzazione di mercato:
$46.26M
Reddito:
$155.00K
Utile/perdita netta:
$-30.01M
Rapporto P/E:
-1.0419
EPS:
-1.67
Flusso di cassa netto:
$-11.98M
1 W Prestazione:
+15.23%
1M Prestazione:
-4.40%
6M Prestazione:
-76.36%
1 anno Prestazione:
-64.42%
Inmune Bio Inc Stock (INMB) Company Profile
Nome
Inmune Bio Inc
Settore
Industria
Telefono
(858) 964-3720
Indirizzo
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Confronta INMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
INMB
Inmune Bio Inc
|
1.74 | 43.87M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-01 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-21 | Iniziato | Alliance Global Partners | Buy |
| 2024-09-27 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-01 | Iniziato | Robert W. Baird | Outperform |
| 2022-05-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-21 | Iniziato | B. Riley Securities | Buy |
| 2021-01-22 | Reiterato | Maxim Group | Buy |
| 2020-09-01 | Iniziato | BTIG Research | Buy |
| 2020-07-15 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Inmune Bio Inc Borsa (INMB) Ultime notizie
Inmune Bio announces new executive employment agreements with compensation details By Investing.com - Investing.com South Africa
Inmune Bio Announces New Executive Employment Agreements - TipRanks
Inmune Bio announces new executive employment agreements with compensation details - Investing.com UK
How INmune Bio Inc. stock performs in high volatility marketsTrade Volume Summary & Technical Pattern Alert System - moha.gov.vn
Block Trades: Why analysts upgrade INmune Bio Inc. stockTrade Analysis Report & High Win Rate Trade Alerts - BỘ NỘI VỤ
INmune Bio Inc Stock Analysis and ForecastStock Buy Signals & Minimal Capital Appreciation - earlytimes.in
Is INmune Bio Inc. stock positioned for long term growth2025 Technical Overview & Technical Buy Zone Confirmation - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
Is INmune Bio Inc. a candidate for recovery playWeekly Gains Report & Consistent Profit Alerts - newser.com
Why INmune Bio Inc. stock is a value investor pickRisk Management & Daily Entry Point Alerts - newser.com
Heatmap analysis for INmune Bio Inc. and competitorsWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Short interest data insights for INmune Bio Inc.Market Trend Review & Verified Technical Signals - newser.com
How INmune Bio Inc. stock benefits from global expansionMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Candlestick signals on INmune Bio Inc. stock today2025 Momentum Check & Expert Curated Trade Ideas - newser.com
INmune Bio (INMB) Stock Analysis Report | Financials & Insights - Benzinga
INmune Bio Inc. (INMB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Does INmune Bio Inc. stock trade at a discount to peers2025 Market Outlook & Growth Focused Investment Plans - newser.com
[Form 4] Inmune Bio, Inc. Insider Trading Activity - Stock Titan
INmune Bio Approves Option Repricing Proposal - TipRanks
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
INmune Bio, Inc. Announces Presentations at 18th Clinical Trials on Alzheimer’s Disease Conference - Quiver Quantitative
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference - Bluefield Daily Telegraph
INmune Bio (INMB) plans XPro1595 Phase 2 Alzheimer’s and EMACC talks at 18th CTAD - Stock Titan
How INmune Bio Inc. stock reacts to Fed rate cutsJuly 2025 Technicals & Expert Curated Trade Setup Alerts - newser.com
INmune Bio Inc.Common stock (NQ: INMB - FinancialContent
Statistical indicators supporting INmune Bio Inc.’s strengthShare Buyback & AI Powered Market Trend Analysis - newser.com
Will INmune Bio Inc. stock outperform tech sector in 2025Weekly Profit Report & Proven Capital Preservation Methods - newser.com
Sentiment analysis tools applied to INmune Bio Inc.Dollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
INmune Bio Inc (0Y2.BE) stock price, news, quote and history - Yahoo Finance Singapore
Inmune Bio Inc Azioni (INMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):